Success stories
Our success is their success: alumni developing radical therapeutic innovations.
| Geneuro GeNeuro is developing a pioneering new approach to the therapy of diseases associated with human endogenous retrovirus expression, including multiple sclerosis. A monoclonal antibody that inhibits the effect of the toxic protein on the surface of the retrovirus has shown exceptional pharmacological results, and has created real hopes of halting the progression of the disease. . www.geneuro.com |
| GenKyoTex GenKyoTex offers an innovative approach to the treatment of pathologies linked to accelerated cell ageing. It is developing inhibitors for NADPH oxidase, a class of enzymes implicated in cell oxidative stress, with diabetic nephropathy as the first indication. www.genkyotex.com |
| Arisgen Arisgen is developing proprietary formulation technologies to improve the biopharmaceutical properties of peptides and proteins, active substance delivery and non-invasive administration techniques. www.arisgen.com |
| Melcure MelCure is developing innovative therapies for melanoma and other cancers, focusing on receptors which promote cell growth during embryonic and cancer development. info[at]melcure.com |
| Epithelix Epithelix is an innovative company specialising in tissue engineering. It offers a unique in-vitro form of human respiratory epithelium, offering an effective and durable alternative to animal experimentation. The company also provides high-volume molecular screening and testing services to the pharmaceutical, chemical and cosmetic industries. www.epithelix.com |
| OncoXL ONCO XL researches and develops innovative tests for early tumour diagnosis. Its revolutionary patented approach is based on the detection of altered nucleic acids circulating in the patient’s blood and linked to the disease. info[at]oncoxl.com |
| Fondation Mintaka Mintaka is a non-profit foundation based in Geneva and officially recognised by the Swiss government as being of public benefit. It makes the results of advanced biomedical research available to developing countries, and is developing microbicidal gels to provide women with effective protection against the Aids virus. www.mintakafoundation.org |
| Drugdesigntech Drugdesigntech develops innovative IT solutions to help biotech and pharmaceutical companies discover new drugs by analysing the molecules’ physical, chemical and safety properties and producing predictive toxicology models. |
